Business Description
Hadasit Bio Holdings Ltd
ISIN : IL0010954050
Total Employee Number:
2Description
Hadasit Bio Holdings Ltd serves as a precedent in the field of biotech financing. It is engaged in the advancement and enhancement of its portfolio companies. Its portfolio companies are involved in the field of medical and biotechnological research and production and distribution of the results of the research and development done in these areas.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.44 | |||||
Equity-to-Asset | -0.01 | |||||
Debt-to-Equity | -60.71 | |||||
Debt-to-EBITDA | -0.61 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 62.1 | |||||
3-Year EPS without NRI Growth Rate | 13.6 | |||||
3-Year FCF Growth Rate | 6.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.99 | |||||
Cash Ratio | 0.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 8.19 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -223.62 | |||||
ROA % | -87.56 | |||||
ROIC % | -321.19 | |||||
3-Year ROIIC % | -4.36 | |||||
ROCE % | -164.4 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -4.48 | |||||
EV-to-EBITDA | -4.48 | |||||
EV-to-FCF | -4.39 | |||||
Earnings Yield (Greenblatt) % | -22.32 | |||||
FCF Yield % | -21.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HSITF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hadasit Bio Holdings Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.027 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.58 | ||
| 3-Year Sortino Ratio | 417.28 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.12 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.12 - 0.12 | ||
| Shares Outstanding (Mil) | 11.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hadasit Bio Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hadasit Bio Holdings Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2016-07-25 | 0.52 (+0.00%) | ||
| 0.2:1 Stock Split | 2015-06-08 | 1.48 (+0.00%) |
Show
Entries
Hadasit Bio Holdings Ltd Frequently Asked Questions
What is Hadasit Bio Holdings Ltd(HSITF)'s stock price today?
The current price of HSITF is $0.12. The 52 week high of HSITF is $0.12 and 52 week low is $0.12.
When is next earnings date of Hadasit Bio Holdings Ltd(HSITF)?
The next earnings date of Hadasit Bio Holdings Ltd(HSITF) is .
Does Hadasit Bio Holdings Ltd(HSITF) pay dividends? If so, how much?
Hadasit Bio Holdings Ltd(HSITF) does not pay dividend.
Guru Commentaries on OTCPK:HSITF
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Hadassah Medical Organization and Bar-Ilan University Collaborate with Immix BioPharma for the Further Development and Commercialization of Next-Generation CAR-T Therapy | 2023-01-04 |
Articles on Hadasit Bio Holdings Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers